Personalized Medicine Disease Modeling | Personalized Medicine Research | Corning

We use cookies to ensure the best experience on our website.
View Cookie Policy
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

Generate more predictive disease models to better understand disease behavior and develop more precise medical treatments

Generate more predictive disease models to better understand disease behavior and develop more precise medical treatments

Personalized medicine enables targeted treatment for an individual at a molecular and pharmacogenomic level to maximize the effect of treatment. Organoids, derived from an individual’s stem cells, progenitor cells, or from induced pluripotent stem cells can be used for disease modeling, to test the efficiency and dosage of a drug, and for regenerative medicine—all at a personalized level.

Testimonials

Customer Success Stories

Featured Resources

Cancer cells

CRISPR and Cytotoxicty Against Cancer Cells

Read more about an approach using CRISPR/Cas9 mediated immune technology that revolutionizes genomic editing by enabling RNA-guided, site-specific DNA cleavage with high efficiency, which holds a great potential for curing disease.

Learn More

3D Models and Human Pancreatic Cancer

3D Models and Human Pancreatic Cancer

Discover how 3D models are being explored such as neoplastic pancreatic organoids that better mimic in vivo physiology and are thought to be better predictors for compound profiling.

Learn More

Support

Scientific Support—Setting a New Industry Standard